ProKidney Corp/$PROK
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ProKidney Corp
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
Ticker
$PROK
Sector
Primary listing
Employees
204
Headquarters
Website
ProKidney Corp Metrics
BasicAdvanced
$381M
-
-$0.55
-
-
Price and volume
Market cap
$381M
52-week high
$7.13
52-week low
$0.55
Average daily volume
2.1M
Financial strength
Current ratio
10.322
Quick ratio
9.392
Long term debt to equity
1.019
Total debt to equity
1.331
Interest coverage (TTM)
-33,176.60%
Profitability
EBITDA (TTM)
-159.571
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-9,547.45%
Operating margin (TTM)
-22,296.10%
Effective tax rate (TTM)
-2.38%
Management effectiveness
Return on assets (TTM)
-25.09%
Return on equity (TTM)
-41.81%
Valuation
Price to revenue (TTM)
492.091
Price to book
-0.38
Price to tangible book (TTM)
-0.38
Price to free cash flow (TTM)
-2.495
Free cash flow yield (TTM)
-40.08%
Free cash flow per share (TTM)
-1.122
Growth
Earnings per share change (TTM)
-2.16%
3-year earnings per share growth (CAGR)
32.74%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ProKidney Corp stock?
ProKidney Corp (PROK) has a market cap of $381M as of November 12, 2025.
What is the P/E ratio for ProKidney Corp stock?
The price to earnings (P/E) ratio for ProKidney Corp (PROK) stock is 0 as of November 12, 2025.
Does ProKidney Corp stock pay dividends?
No, ProKidney Corp (PROK) stock does not pay dividends to its shareholders as of November 12, 2025.
When is the next ProKidney Corp dividend payment date?
ProKidney Corp (PROK) stock does not pay dividends to its shareholders.
What is the beta indicator for ProKidney Corp?
ProKidney Corp (PROK) does not currently have a Beta indicator.